{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:43:39Z","timestamp":1762821819261,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.retram.2023.103387","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T04:27:33Z","timestamp":1679372853000},"page":"103387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-9428","authenticated-orcid":false,"given":"Jean","family":"El Cheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layal","family":"Sharrouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Hamade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khodr","family":"Terro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan","family":"Bidaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Charafeddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"Zahreddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Moukalled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Abou Dalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.retram.2023.103387_bib0001","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bmt.2014.312","article-title":"Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants","volume":"50","author":"Passweg","year":"2015","journal-title":"Bone Marrow Transplant (Basingstoke)"},{"issue":"10","key":"10.1016\/j.retram.2023.103387_bib0002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","article-title":"Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts","volume":"20","author":"Raiola","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2023.103387_bib0003","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/bmt.2013.139","article-title":"Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival","volume":"49","author":"Rogosheske","year":"2014","journal-title":"Bone Marrow Transplant (Basingstoke)"},{"issue":"4","key":"10.1016\/j.retram.2023.103387_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41409-022-01598-6","article-title":"Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study","volume":"57","author":"H\u00e9ritier","year":"2022","journal-title":"Bone Marrow Transplant (Basingstoke)"},{"issue":"Suppl1","key":"10.1016\/j.retram.2023.103387_bib0005","first-page":"302","article-title":"Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients","volume":"18","author":"Tafazoli","year":"2019","journal-title":"Iran J Pharm Res"},{"issue":"3","key":"10.1016\/j.retram.2023.103387_bib0006","article-title":"Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation","volume":"14","author":"EAd","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.retram.2023.103387_bib0007","first-page":"620682","article-title":"Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation","volume":"2014","author":"Garc\u00eda Cadenas","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.retram.2023.103387_bib0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ejh.13233","article-title":"Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation","volume":"103","author":"Stocker","year":"2019","journal-title":"Eur J Haematol"},{"issue":"8","key":"10.1016\/j.retram.2023.103387_bib0009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1704213","article-title":"Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors","volume":"32","author":"Martin","year":"2003","journal-title":"Bone Marrow Transplant (Basingstoke)"},{"issue":"4","key":"10.1016\/j.retram.2023.103387_bib0010","doi-asserted-by":"crossref","first-page":"e13220","DOI":"10.1111\/ctr.13220","article-title":"Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation","volume":"32","author":"Yang","year":"2018","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.retram.2023.103387_bib0011","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bmt.1701031","article-title":"Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience","volume":"20","author":"Lamparelli","year":"1997","journal-title":"Bone Marrow Transplant (Basingstoke)"},{"issue":"6","key":"10.1016\/j.retram.2023.103387_bib0012","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbmt.2009.03.004","article-title":"Early (Day \u22127) versus Conventional (Day \u22121) Inception of Cyclosporine-A for Graft-versus-Host Disease Prophylaxis after Unrelated Donor Hematopoietic Stem Cell Transplantation in Children. Long-Term Results of an AIEOP Prospective, Randomized Study","volume":"15","author":"Lanino","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"10.1016\/j.retram.2023.103387_bib0013","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1182\/blood.V114.22.1143.1143","article-title":"The optimal initiation timing for cyclosporine in allogeneic transplantation, earlier is better with the price of higher rate of chronic Gvhd","volume":"114","author":"Dray","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103387_bib0014","volume":"28","author":"Battipaglia","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:39:41Z","timestamp":1762821581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2452318623000119"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103387","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103387"}}